News and commentary from the endocrinology world
— News and commentary from the endocrinology world
June 9, 2026
• 2 min read
Investigational apitegromab -- a selective myostatin activation inhibitor -- effectively preserved lean mass when combined with tirzepatide (Zepbound) in a randomized phase II trial, suggesting it could help fight "Ozempic butt." (Nature Medicine, BBC News)
The FDA hasn't yet reviewed retatrutide for safety and effectiveness, but doctors are prescribing the investigational weight-loss drug anyhow. (CBS News)
This drug can help retain muscle during weight loss
Retatrutide benefits in obesity, type 2 diabetes ‘quite staggering’
Muscle-boosting drug could help retain lean tissue when using weight-loss jabs
How a new drug could stop muscle-loss side effect of obesity jabs
Petrelintide, a novel amylin analog, induces 10% weight loss, very well tolerated
Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
Muscle growth drug ‘could reduce loss of lean tissue’ when using slimming jabs
The GLP-1 Era: How To Lose Weight Without Losing Muscle
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
A new drug promoting muscle growth may help counteract the significant lean body mass loss—up to 40%—associated with GLP-1-based…
A once-weekly triple receptor agonist conferred up to 28.3% weight loss at 80 weeks for adults with overweight or obesity,…
News and commentary from the endocrinology world
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with…
NEW ORLEANS —A triple receptor agonist provided weight loss for adults with obesity, with or without type 2 diabetes, to an…
Researchers found the use of a lab-made antibody can help retain lean body mass when using weight-loss jabs
